|1|miR-34a/SIRT1/p53 is suppressed by ursodeoxycholic acid in the rat liver and activated by disease severity in human non-alcoholic fatty liver disease. (22902550)
Castro R.E.... Rodrigues C.M.
|2|Serum uric acid levels and non-alcoholic fatty liver disease in Uyghur and Han ethnic groups in northwestern China. (24343630)
Cai W.... Yao H.
|3|Silymarin in non alcoholic fatty liver disease. (23556042)
Cacciapuoti F.... Cacciapuoti F.
|4|Oxymatrine ameliorates non-alcoholic fatty liver disease in rats through peroxisome proliferator-activated receptor-I+ activation. (23754536)
Shi L.... Song G.
|5|Primary non-alcoholic fatty liver disease in hypertensive patients. (23837080)
Latea L.... Bolboaca S.
|6|Green tea with high-density catechins improves liver function and fat infiltration in non-alcoholic fatty liver disease (NAFLD) patients: a double-blind placebo-controlled study. (24065295)
Sakata R.... Sata M.
|7|Assessment of splenic perfusion in patients with malignant hematologic diseases and spleen involvement, liver cirrhosis and controls using volume perfusion CT (VPCT): a pilot study. (22326669)
Sauter A.W.... Horger M.S.
|8|Hepatitis E infection is an under recognized cause of acute decompensation in patients with chronic liver disease. (22592074)
De Silva S.... Verma S.
|9|Boy with autosomal recessive polycystic kidney and autosomal dominant polycystic liver disease. (22415584)
Zingg-Schenk A.... Neuhaus T.J.
|10|Loss of heterozygosity is present in SEC63 germline carriers with polycystic liver disease. (23209713)
Janssen M.J.... Drenth J.P.
|11|Safety of liver transplantation with Chagas disease-seropositive donors for seronegative recipients. (21618698)
Salvador F.... Pahissa A.
|12|Hepatocellular MxA protein expression supports the differentiation of recurrent hepatitis C disease from acute cellular rejection after liver transplantation. (19712085)
MacQuillan G.C.... Jeffrey G.P.
|13|Liver disease without flipping: new functions of ATP8B1, the protein affected in familial intrahepatic cholestasis type 1. (20512981)
|14|Extended liver resection for polycystic liver disease can challenge liver transplantation. (21037428)
Aussilhou B.... Belghiti J.
|15|Levels of soluble CD40 ligand and P-Selectin in nonalcoholic fatty liver disease. (19440836)
Ercin C.N.... Kemal Erbil M.
|16|Recurrence of autoimmune disease, primary sclerosing cholangitis, primary biliary cirrhosis, and autoimmune hepatitis after liver transplantation. (19876939)
Duclos-Vallee J.C.... Sebagh M.
|17|Polycystic liver disease treated with therapeutic excision. (19752867)
Das K.K.... Radhakrishnan J.
|18|High serum adiponectin correlates with advanced liver disease in patients with chronic hepatitis B virus infection. (19669362)
Liu C.J.... Chen D.S.
|19|Linezolid an oral treatment option for staphylococcal liver abscess in chronic granulomatous disease. (19859022)
Erlewyn-Lajeunesse M.... Faust S.N.
|20|Glutathione in liver diseases and hepatotoxicity. (18786561)
Yuan L.... Kaplowitz N.
|21|Serum leptin and soluble leptin receptor in non-alcoholic fatty liver disease. (18473416)
Huang X.D.... Zhan X.Y.
|22|Effect of alcohol on miR-212 expression in intestinal epithelial cells and its potential role in alcoholic liver disease. (18162065)
Tang Y.... Keshavarzian A.
|23|Does retinol-binding protein 4 cause or reflect fatty liver disease? (18570262)
BlA1her M.... Stumvoll M.
|24|TGF-beta1 and C-erb-B2 neu oncoprotein in Egyptian HCV related chronic liver disease and hepatocellular carcinoma patients. (20306668)
El Bassuoni M.A.... Shaker O.T.
|25|Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. (18591439)
Schwimmer J.B.... Cook S.
|26|Nonalcoholic fatty liver disease as a risk factor of cardiovascular disease: relation of non-alcoholic fatty liver disease to carotid atherosclerosis]. (18367860)
Choi S.Y.... Lee H.S.
|27|Reduced mobilisation of hematopoietic stem cells after hepatic resection for malignant liver disease. (18752047)
Menegazzo M.... Corsini A.
|28|Liver X receptor-mediated gene regulation and cholesterol homeostasis in brain: relevance to Alzheimer's disease therapeutics. (17430244)
Cao G.... Paul S.M.
|29|The serum level of certain aminoacids in chronic liver diseases associated with impaired oral glucose tolerance. (17236290)
SAcmpelean D.... Vlad C.
|30|Association between vitamin D receptor, CCR5, TNF-alpha and TNF-beta gene polymorphisms and HBV infection and severity of liver disease. (16545485)
Suneetha P.V.... Hissar S.
|31|Serum levels of hepatoprotective peptide adiponectin in non-alcoholic fatty liver disease. (16394799)
Aygun C.... Canturk Z.
|32|Leptin and fatty liver disease]. (15329225)
Zhao C.Y.... Li L.
|33|Immunohistochemical detection of 1,N6-ethenodeoxyadenosine in nuclei of human liver affected by diseases predisposing to hepato-carcinogenesis. (14742317)
Frank A.... Nair J.
|34|Plasma P-selectin levels are elevated in patients with chronic liver disease. (12945872)
Tacke F.... von Depka M.
|35|Bone histomorphometric changes after liver transplantation for chronic cholestatic liver disease. (14672354)
Guichelaar M.M.... Hay J.E.
|36|A new variant neuropathic type of Gaucher's disease characterized by hydrocephalus, corneal opacities, deformed toes, and fibrous thickening of spleen and liver capsules. (11148530)
Inui K.... Okada S.
|37|Independent patterns of cytochrome P450 gene expression in liver and blood in patients with suspected liver disease. (11599658)
FinnstrAPm N.... Rane A.
|38|Splenomegaly, hypersplenism and coagulation abnormalities in liver disease. (11139352)
McCormick P.A.... Murphy K.M.
|39|Review: molecular approaches to inherited liver disease. Focus on Wilson disease. (9407345)
|40|Treatment of veno-occlusive disease of the liver with bolus tissue plasminogen activator and continuous infusion antithrombin III concentrate. (8704704)
Patton D.F.... Haire W.D.
|41|Creutzfeldt-Jakob disease after liver transplantation. (7654078)
CrAcange A.... Degos J.D.
|42|Colchicine in chronic liver disease of alcoholic etiology. Double-blind, randomized study of its effects on blood levels of plasma proteins and clinical course in patients]. (8574231)
Parise E.R.... Vilela M.P.
|43|Liver lesion on computed tomography and ultrasonography in adult Niemann Pick disease related to sea blue histiocyte syndrome--a case report. (8325590)
Strigaris K.... Nikolacopoulou Z.
|44|Pathogenesis of sodium and water retention in liver disease. (1296235)
Niederberger M.... Schrier R.W.
|45|Metabolic alkalosis as driving force for urea synthesis in liver disease: pathogenetic model and therapeutic implications. (1600351)
HAoussinger D.... Gerok W.
|46|Alpha-fetoprotein alterations in alcoholics with liver disease. V.A. Cooperative Study Groups. (1725107)
Mendenhall C.L.... Gartside P.S.
|47|Clinicopathological analysis of alcoholic liver disease complicating chronic type C hepatitis. (1943504)
Noguchi O.... Uchida T.
|48|Changes of dipeptidylpeptidase IV as a membrane marker of lymphocytes in acute and chronic liver diseases--biochemical and cytochemical investigations. (1681896)
Nilius R.... Dietrich R.
|49|Hyperprolinemia and lactatemia in alcoholic liver disease: relationships to abstinence and histological findings. (2312066)
|50|Diminished micellar phase lipid in patients with chronic nonalcoholic liver disease and steatorrhea. (5423890)
Badley B.W.... Sherlock S.